Access cutting-edge heart and kidney disease treatment through this clinical trial at a research site in Surprise. Study-provided care at no cost to qualified participants.
Access heart and kidney disease specialists in Surprise at no cost
This study follows strict safety protocols and ethical guidelines
All study-related heart and kidney disease treatment provided free
This study is open to adults with chronic kidney disease at risk of progression. People with and without type 2 diabetes can take part in this study. The study is open to people who take other medicines called angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB). People who already take empagliflozin or any other sodium-glucose cotransporter-2 inhibitor (SGLT2i) can also join. The study is also open to people who currently do not take any of these treatments. Th
Sponsor: Boehringer Ingelheim
Check if you qualify for this heart and kidney disease clinical trial in Surprise, AZ
If you're searching for heart and kidney disease treatment options in Surprise, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Surprise research site is actively enrolling participants for this clinical trial. You'll receive care from experienced heart and kidney disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.